Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7191 results

AbbVie fourth-qtr beats forecasts, but posts Shire-associated $810 million loss

31-01-2015

US drugmaker AbbVie (NYSE: ABBV) on Friday announced financial results for the fourth quarter and full…

AbbVieAnti-Arthritics/RheumaticsAnti-viralsFinancialHumiraPharmaceuticalViekira Pak

Eli Lilly's fourth quarter financials hit by patent expiries and currency issues

Eli Lilly's fourth quarter financials hit by patent expiries and currency issues

30-01-2015

US drugmaker Eli Lilly’s fourth quarter financials were hit by genericization and currency fluctuations,…

CymbaltaEli LillyEvistaFinancialPharmaceutical

Janssen's Prezcobix approved for HIV in the USA

Janssen's Prezcobix approved for HIV in the USA

30-01-2015

The US Food and Drug Administration has approved Prezcobix (darunavir 800mg/cobicistat 150mg) tablets,…

Anti-viralsJanssenPharmaceuticalPrezcobixRegulationUSA

FDA expands approval of Johnson & Johnson/Pharmacyclics' Imbruvica to Waldenstrom’s macroglobulinemia

FDA expands approval of Johnson & Johnson/Pharmacyclics' Imbruvica to Waldenstrom’s macroglobulinemia

30-01-2015

The US Food and Drug Administration has expanded approval of Johnson & Johnson and Pharmacyclics’ Imbruvica…

HematologyImbruvicaJohnson & JohnsonPharmaceuticalPharmacyclicsRegulationUSA

Modest growth expected for Asia-Pacific ovarian cancer drug market

30-01-2015

The Asia-Pacific (APAC) therapeutics market for ovarian cancer (OC) will undergo a modest rise in value,…

Asia-PacificOncologyPharmaceutical

Strong sales and earnings growth for Novo Nordisk in 2014

30-01-2015

Danish diabetes care giant Novo Nordisk posted financials this morning, showing that sales for full-year…

DiabetesFinancialNovo NordiskPharmaceutical

Abbott's last quarter 2014 results come in below estimates

Abbott's last quarter 2014 results come in below estimates

29-01-2015

Currency fluctuations are a cause for concern for US health care company Abbott Laboratories, as it reports…

AbbottAbbott LaboratoriesFinancialPharmaceuticalUSA

Baxter says record 2014 results set solid foundation for planned separation

29-01-2015

US drugmaker Baxter International today announced fourth quarter 2014 financial results that exceeded…

Baxter InternationalFinancialPharmaceutical

Phase III trial shows Novartis' Jakavi significantly improves hematocrit control

Phase III trial shows Novartis' Jakavi significantly improves hematocrit control

29-01-2015

Results from the pivotal Phase III trial of Jakavi (ruxolitinib) carried out by Swiss drug major Novartis…

HematologyJakaviNovartisPharmaceuticalResearch

GSK and Novartis get European clearance for asset swap

GSK and Novartis get European clearance for asset swap

29-01-2015

UK pharma major GlaxoSmithKline has received clearance from the European Commission for its proposed…

EuropeFinancialGlaxoSmithKlineNovartisOncologyPharmaceuticalUK

Long-term solutions needed for kidney disease, says EAF report

Long-term solutions needed for kidney disease, says EAF report

29-01-2015

Greater education and support for non-specialist health care professionals is needed to ensure the accurate…

EuropeHealthcareNephrology and HepatologyOtsuka PharmaceuticalPharmaceutical

Applied Molecular Transport inks research and license agreement with Janssen on IBD therapy

Applied Molecular Transport inks research and license agreement with Janssen on IBD therapy

28-01-2015

Biopharma company Applied Molecular Transport has entered into a research collaboration and license agreement…

Applied Molecular TransportGastro-intestinalsJanssenJohnson & JohnsonLicensingPharmaceutical

US House Energy & Commerce Committee releases 21 Century Cures Act discussion draft

US House Energy & Commerce Committee releases 21 Century Cures Act discussion draft

28-01-2015

The promised January 2015 release of a discussion draft of legislation to implement the 21st Century…

PatentsPharmaceuticalPoliticsResearchUSA

Ferring appoints Pascal Danglas and Per Falk to senior positions

Ferring appoints Pascal Danglas and Per Falk to senior positions

28-01-2015

Switzerland-headquartered Ferring Pharmaceuticals has appointed Pascal Danglas as executive vice president…

BoardroomFerring PharmaceuticalsPascal DanglasPharmaceuticalSwitzerland

Roche’s 2014 profits miss forecasts, impacted by costs

Roche’s 2014 profits miss forecasts, impacted by costs

28-01-2015

Despite posting higher sales for full-year 2014, Swiss pharma major Roche missed analysts’ forecasts,…

FinancialPharmaceuticalReutersRocheUnited States

Russia may face shortage of anti-AIDS drugs in 2015

Russia may face shortage of anti-AIDS drugs in 2015

28-01-2015

Russia may face with a shortage of anti-AIDS drugs in 2015 due to the current complex situation in the…

Anti-viralsHealthcareMarkets & MarketingPharmaceuticalRussia

Biomay announces positive Phase IIb study of BM32 grass pollen vaccine

Biomay announces positive Phase IIb study of BM32 grass pollen vaccine

28-01-2015

Vienna-based allergy immunotherapy specialist Biomay has successfully completed a Phase IIb study of…

BiomayBM32ImmunologicalsPharmaceuticalResearchSwitzerland

Beximco Pharma borrows $51.5 million to fund expansion

28-01-2015

Bangladesh-based Beximco Pharmaceuticals has entered into a new loan agreement to borrow up to $51.559…

BangladeshBeximco PharmaBeximco PharmaceuticalsFinancialPharmaceutical

Amgen and Onyx submit Kyprolis sNDA and marketing authorization application in USA and EU

Amgen and Onyx submit Kyprolis sNDA and marketing authorization application in USA and EU

28-01-2015

USA-based Amgen, the world’s leading independent biotech firm, and its subsidiary Onyx Pharmaceuticals…

AmgenKyprolisOncologyOnyx PharmaceuticalsPharmaceuticalRegulationUSA

iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

28-01-2015

Ophthalmic specialist iCura Vision has licensed the intellectual property portfolio and associated research…

iCura VisionLicensingOphthalmicsPharmaceuticalUSA

Fourth quarter Bristol-Myers Squibb results disappoint

Fourth quarter Bristol-Myers Squibb results disappoint

27-01-2015

Although the fourth quarter financial results from US drug major Bristol-Myers Squibb beat analyst estimates,…

Bristol-Myers SquibbFinancialPharmaceuticalUnited StatesUSA

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

27-01-2015

US pharma giant Pfizer today reported fourth-quarter 2014 earnings of $1.23 billion, and net earnings…

Corporate crimeDow Jones Industrial AverageFinancialPfizerPharmaceutical

1 to 25 of 7191 results

Back to top